Trial intelligence / Profile preview

Methenamine hippurate to reduce antibiotic prescribing in elderly women with recurrent urinary tract infection

2018-002235-15Phase 4Completed

Sponsor
University of Oslo
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial in urinary tract infection (UTI) comparing Methenamine hippurate (Hiprex) with Placebo (2 arms). Primary endpoint: Number of antibiotic courses during the first half year of treatment. Started Dec 2019; status: completed.

02

Drugs

methenamine hippurate
03

Conditions

urinary tract infection (UTI)

Beyond the preview

Go deeper on 2018-002235-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-002235-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call